C16ORF63 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.518800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.472200E-01
Normal-vs-Stage2
7.450800E-01
Normal-vs-Stage3
8.915900E-02
Normal-vs-Stage4
9.691200E-01
Stage1-vs-Stage2
7.076400E-01
Stage1-vs-Stage3
4.684400E-02
Stage1-vs-Stage4
9.122400E-01
Stage2-vs-Stage3
6.677700E-02
Stage2-vs-Stage4
6.693600E-01
Stage3-vs-Stage4
1.139440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.384600E-01
Normal-vs-AfricanAmerican
8.154400E-01
Normal-vs-Asian
5.673400E-01
Caucasian-vs-AfricanAmerican
3.855800E-01
Caucasian-vs-Asian
5.525800E-01
AfricanAmerican-vs-Asian
3.239800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.828600E-01
Normal-vs-Female
8.529600E-01
Male-vs-Female
4.174600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.161600E-01
Normal-vs-Age(41-60Yrs)
8.757200E-01
Normal-vs-Age(61-80Yrs)
5.922000E-01
Normal-vs-Age(81-100Yrs)
7.629600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.170800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.311200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.218800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.455850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.280000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.692800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.624400E-01
Normal-vs-Daily Drinker
5.657400E-01
Normal-vs-Weekly Drinker
4.671200E-01
Normal-vs-Occasional Drinker
9.837400E-01
Normal-vs-Social Drinker
9.842400E-01
Non Drinker-vs-Daily Drinker
7.555400E-01
Non Drinker-vs-Weekly Drinker
9.953800E-01
Non Drinker-vs-Occasional Drinker
1.402790E-01
Non Drinker-vs-Social Drinker
1.773150E-01
Daily Drinker-vs-Weekly Drinker
7.915000E-01
Daily Drinker-vs-Occasional Drinker
2.653000E-01
Daily Drinker-vs-Social Drinker
3.085200E-01
Weekly Drinker-vs-Occasional Drinker
2.115000E-01
Weekly Drinker-vs-Social Drinker
2.541800E-01
Occasional Drinker-vs-Social Drinker
9.980800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.376820E-01
Normal-vs-Grade 2
4.345900E-02
Normal-vs-Grade 3
4.880200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.659600E-01
Grade 1-vs-Grade 3
1.927980E-01
Grade 1-vs-Grade 4
1.376820E-01
Grade 2-vs-Grade 3
6.400600E-01
Grade 2-vs-Grade 4
4.345900E-02
Grade 3-vs-Grade 4
4.880200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.349600E-01
Normal-vs-NonDiabetic
7.761200E-01
Diabetic-vs-NonDiabetic
7.714400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.507400E-01
Normal-vs-NoPancreatitis
7.240600E-01
Pancreatitis-vs-NoPancreatitis
8.877000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.925600E-01
Normal-vs-N1
7.599600E-01
N0-vs-N1
8.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.373600E-01
Normal-vs-TP53-NonMutant
8.616600E-01
TP53-Mutant-vs-TP53-NonMutant
1.337180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
